Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesPharmacy & Specialty Drugsharvard pilgrim step therapy Prior Auth Coverage |…
    Ask Trek AI about this page
    Currentharvard pilgrim health carePolicy N/A

    2026 Step Therapy Prior Authorization for select outpatient drugs

    Customize your policy alerts

    Sign up for all harvard pilgrim health care policy alerts

    Know when harvard pilgrim health care releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Defines Step Therapy requirements for specific outpatient prescription drugs for Tufts Health One Care (HMO D-SNP) members, indicating which products are Step-1 (no prior authorization) vs Step-2 (require previous fill of Step-1/Step-2 agents). Affects providers and pharmacists prescribing or dispensing the listed products.

    Policy Summary
    Payerharvard pilgrim health care
    Policy2026 Step Therapy Prior Authorization for select outpatient drugs
    Policy CodePolicy N/A
    Change TypeNo material changes
    Effective DateJun 1, 2026
    Next Review DateN/A
    Key ActionProvide physician documentation or a paid pharmacy claim showing required Step-1 (or Step-2 where specified) fills within the prior 180 days to meet Step-2 coverage requirements.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    Step-1 vs Step-2drugs categorized into Step tiers
    180

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    lookback period (days)
    12+products listed

    Step Therapy Coverage Criteria by Drug Class

    Antidepressant Step Therapy

    Antidepressant products

    Antidepressant Step-1 coverage: Bupropion, bupropion SR, bupropion XL, citalopram, desvenlafaxine ER, duloxetine delayed-release capsules, escitalopram, fluoxetine, fluoxetine delayed-release, fluvoxamine, paroxetine, sertraline, venlafaxine and venlafaxine ER are on Step-1 and are covered without prior authorization.
    Antidepressant Step-2 coverage: Emsam, Fetzima, and Exxua are on Step-2 and will be covered if the member has filled for a Step-1 or Step-2 medication within the previous 180 days as evidenced by a paid claim or physician documentation.180 days

    Evidence: paid pharmacy claim or physician documentation within 180 days.

    Atypical Antipsychotics Step Therapy

    Atypical antipsychotic products

    Antipsychotic Step-1 coverage: Aripiprazole, lurasidone, olanzapine, olanzapine-fluoxetine, quetiapine, risperidone and ziprasidone are on Step-1 and covered without authorization.
    Antipsychotic Step-2 coverage: Asenapine and Fanapt are on Step-2 and will be covered if the member has filled for one or more Step-1 or Step-2 medications within the previous 180 days as evidenced by a paid claim or physician documentation.180 days

    Evidence: paid pharmacy claim or physician documentation within 180 days.

    Inhaled Steroids Step Therapy

    Inhaled corticosteroid products

    Inhaled steroid Step-1 coverage: QVAR is on Step-1 and covered without authorization.
    Inhaled steroid Step-2 coverage: Fluticasone is on Step-2 and will be covered if the member has filled for one or more Step-1 medications within the previous 180 days as evidenced by a paid claim or physician documentation.180 days

    Evidence: paid pharmacy claim or physician documentation within 180 days.

    MS Therapies Step Therapy

    Multiple sclerosis disease-modifying therapies

    MS DMT Step-1 coverage: Avonex, Betaseron, and Plegridy are on Step-1 and covered without prior authorization.
    MS DMT Step-2 coverage: Rebif and Rebif Rebidose are on Step-2 and will be covered if the member has filled for two or more Step-1 medications within the previous 180 days as evidenced by a paid claim or physician documentation.180 days; 2 fills

    Evidence: two or more paid pharmacy claims or physician documentation within 180 days.

    RequirementAcceptable evidenceLookback period / required fills
    Step therapy prior-fill requirement for Step-2 agentsPaid pharmacy claim showing a fill for the required Step-1 or Step-2 medication or physician documentation confirming the prior fill(s)180 days (lookback). Generally 1 prior fill required; Rebif/Rebif Rebidose require 2 prior Step-1 fills.

    Operational Coding & Lookback

    Prior fill lookback
    Prior fill lookback period180 days
    Evidence acceptedPaid pharmacy claim or physician documentation demonstrating prior fill(s)
    Applies toStep-2 medications across listed drug classes (antidepressants, atypical antipsychotics, inhaled corticosteroids, MS DMTs)
    Count requirementUsually 1 prior fill required; Rebif products require 2 prior Step-1 fills within lookback

    Provider Requirements, Documentation, and Denial Risks

    Step Therapy

    General Step Therapy requirement

    Step therapy is enforced: specified Step-1 agents are covered without prior authorization; specified Step-2 agents require prior evidence of fills within a 180-day lookback. The number of required prior fills varies by drug group (usually one; Rebif requires two).

    • Step-1 agents listed in the policy are covered without prior authorization.
    • Step-2 agents require evidence of prior use of one or more Step-1 (or Step-2 where specified) medications within the previous 180 days.
    • Rebif and Rebif Rebidose require two or more Step-1 medication fills in the 180-day lookback.
    Prior Authorization

    Antidepressant Step Therapy — prior fill required

    Coverage for Emsam, Fetzima, and Exxua (Step-2 antidepressants) requires documentation of a prior Step-1 or Step-2 medication fill within the previous 180 days; without this evidence coverage will not be granted.

    Policy Background and Scope

    This document is a formulary-based step therapy guideline for select outpatient prescription drugs used by Tufts Health One Care (HMO D‑SNP) members. It defines which products are designated Step‑1 (covered without prior authorization) and which are Step‑2 (require evidence of prior therapy) across multiple therapeutic categories including antidepressants, atypical antipsychotics, inhaled corticosteroids, and multiple sclerosis disease‑modifying therapies. The policy is effective 06/01/26 and applies to the products listed in the formulary.

    For Step‑2 coverage the policy requires documentation of prior use as described for each drug group: coverage is granted only when a paid pharmacy claim or physician documentation shows the required prior fills within the policy’s lookback period. The standard lookback period is 180 days; the number of required fills varies by drug group (usually one prior fill, except Rebif products which require two prior Step‑1 fills).

    Operationally, specified Step‑1 agents are available to members without prior authorization and help resolve first‑line prescribing. Specified Step‑2 agents may be covered only after the member meets the stated prior‑therapy requirements documented by a paid claim or physician attestation within the 180‑day window; absent that evidence, claims for Step‑2 agents are subject to denial.

    Step Definitions

    Step-1 — Covered without prior authorization
    DefinitionDrugs listed as covered without prior authorization; members may receive these agents without step edit requirements.
    Antidepressant Step-1 examplesBupropion, bupropion SR, bupropion XL, citalopram, desvenlafaxine ER, duloxetine delayed-release capsules, escitalopram, fluoxetine, fluoxetine delayed-release, fluvoxamine, paroxetine, sertraline, venlafaxine, venlafaxine ER
    MS DMT Step-1 examplesAvonex, Betaseron, Plegridy
    Antipsychotic Step-1 examplesAripiprazole, lurasidone, olanzapine, olanzapine-fluoxetine, quetiapine, risperidone, ziprasidone
    Inhaled steroid Step-1 exampleQVAR
    Step-2 — Prior therapy required
    Policy Summary
    Payerharvard pilgrim health care
    Policy2026 Step Therapy Prior Authorization for select outpatient drugs
    Policy CodePolicy N/A
    Change TypeNo material changes
    Effective DateJun 1, 2026
    Next Review DateN/A
    Key ActionProvide physician documentation or a paid pharmacy claim showing required Step-1 (or Step-2 where specified) fills within the prior 180 days to meet Step-2 coverage requirements.
    SourceLink
    On This Page
    Step Therapy Coverage Criteria by Drug ClassOperational Coding & LookbackProvider Requirements, Documentation, and Denial RisksPolicy Background and ScopeStep Definitions
  1. Acceptable evidence: paid pharmacy claim or physician documentation showing a fill within the prior 180 days.
  2. Prior Authorization

    Atypical antipsychotic Step Therapy — prior fill required

    Coverage for Asenapine and Fanapt (Step-2 atypical antipsychotics) requires evidence of one or more Step-1 or Step-2 medication fills within the previous 180 days as shown by a paid claim or physician documentation.

    • Provide a paid pharmacy claim or physician documentation demonstrating the required fill(s) within 180 days.
    Prior Authorization

    Inhaled steroid Step Therapy — Fluticasone prior fill required

    Fluticasone (Step-2 inhaled steroid) will be covered only if there is evidence of a Step-1 medication fill within the previous 180 days; submit a paid claim or physician documentation to demonstrate prior use.

    • QVAR is Step-1 and is covered without authorization; Fluticasone requires the Step-1 fill lookback.
    Prior Authorization

    MS therapy Step Therapy — two prior Step-1 fills required

    Rebif and Rebif Rebidose (Step-2 MS therapies) require evidence of two or more Step-1 medication fills within the previous 180 days for coverage; provide paid pharmacy claims or physician documentation to meet this requirement.

    • Avonex, Betaseron, and Plegridy are Step-1 (covered without prior authorization).
    • Rebif products require two or more Step-1 fills in the 180-day lookback.
    Documentation Required

    Evidence to support prior therapy

    Physician documentation or a paid pharmacy claim within the previous 180 days demonstrating a fill for the required Step-1 or Step-2 medication(s) must be submitted to support Step-2 coverage requests.

    • Documentation must clearly identify the medication and date of fill within the 180-day lookback.
    Denial Risk

    Denial risk — Step-2 antidepressants

    Coverage for Step-2 agents (for example, Emsam, Fetzima, Exxua) will be denied unless the member has a paid claim or physician documentation showing prior therapy with a Step-1 or Step-2 medication within the previous 180 days.

    • If no acceptable evidence of prior fill is provided within 180 days, the request should be denied per policy.
    Denial Risk

    Denial risk — Step-2 atypical antipsychotics

    Coverage for Asenapine and Fanapt will be denied unless the member has filled one or more Step-1 or Step-2 medications within the previous 180 days as evidenced by a paid claim or physician documentation.

    • Absent acceptable prior-fill evidence within the 180-day lookback, coverage must be denied.
    Denial Risk

    Denial risk — Fluticasone (inhaled steroid)

    Coverage for Fluticasone will be denied unless the member has a paid claim or physician documentation showing a Step-1 medication fill within the previous 180 days.

    • QVAR is Step-1 (no prior authorization); Fluticasone requires proof of Step-1 fill in the lookback to avoid denial.
    Denial Risk

    Denial risk — Rebif products (interferons)

    Coverage for Rebif and Rebif Rebidose requires evidence of two or more Step-1 medication fills within the previous 180 days; without such evidence, coverage will be denied.

    • Submit paid pharmacy claims or physician documentation demonstrating two or more Step-1 fills within 180 days to meet the requirement.
    DefinitionDrugs that require evidence of prior use of one or more Step-1 (or Step-2 where specified) medications within the prior 180 days as shown by paid claim(s) or physician documentation in order to be covered.
    Antidepressant Step-2 examples and requirementEmsam, Fetzima, Exxua — covered only if member has a paid claim or physician documentation showing a Step-1 or Step-2 fill within the previous 180 days
    Antipsychotic Step-2 examples and requirementAsenapine, Fanapt — covered only if member has filled one or more Step-1 or Step-2 medications within the previous 180 days (paid claim or physician documentation)
    Inhaled steroid Step-2 example and requirementFluticasone — covered only if member has filled one or more Step-1 medications within the previous 180 days (paid claim or physician documentation)
    MS DMT Step-2 examples and requirementRebif, Rebif Rebidose — covered only if member has filled two or more Step-1 medications within the previous 180 days (paid claim or physician documentation)